close icon

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever.

An indeed, fundamentally, Lockheed is a top-notch company and was hardly overvalued at the time. It has been growing both revenues and profits using relatively little debt over the years. Nevertheless, instead of joining the bulls right away, we decided to take a look at its weekly chart first.

Lockheed Martin stock was vulnerable in mid-2019

The company’s weekly chart revealed that the uptrend from $16.38 in 1999 was taking the shape of a clear five-wave impulse. We labeled it (1)-(2)-(3)-(4)-(5), where the sub-waves of both (1) and (3) were also visible. The two corrective waves – (2) and (4) – had retraced to the 61.8% and 38.2% Fibonacci levels, respectively.

The analysis led us to believe that wave (5) was in progress. Unfortunately for Lockheed investors, the Elliott Wave principle states that a three-wave correction follows every impulse. So, we concluded that “a bearish reversal can soon occur, followed by a 40-50% drop in the next few years.

Lockheed Can Lose Another 30% From Current Levels

The bulls managed to add another $73 dollars to Lockheed’s per share price by February 2020. Then, COVID-19 struck.

Lockheed Martin stock can drop 30% before the bulls return

In just a month during the coronavirus selloff, LMT stock fell by 40% from $443 to $266 a share. That drop was sharp and fast, but still too shallow for us to be able to conclude the correction is over. In addition, the structure of the following recovery to $418 by June 2020 looks corrective, as well.

If this count is correct, the March plunge must be labeled as wave (a) of a simple (a)-(b)-(c) zigzag which is still unfolding. The rally to $418 must be wave (b), meaning wave (c) can be expected to drag Lockheed down again. Wave (c) is supposed to breach the bottom of wave (a), making bearish targets near $240 plausible.

This translates into another 30% decline to the support of wave (4) before the bulls can return. Lockheed can be a wonderful buy-and-hold stock in the long-term. However, we think investors can get a much better price if only they wait a few more months.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Undervalued Bristol Myers Stock Can Still Get Cheaper

It’s been almost two years since we shared our bullish stance on Bristol Myers stock. Shares in the pharmaceutical major were changing hands for less than $46 in April, 2019. The company had just announced its planned acquisition of Celgene for about $74 billion and Wall Street apparently didn’t like the risks involved. However, the…

Read More »

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Campari Bulls to Get a Serious Hangover Soon

Campari is an Italian liquor and spirits maker with traditions dating back to 1860. The company’s stock price plunged sharply in March along with the markets in general and then recovered just as quickly to new records by year-end. As shares hover near all-time highs, however, dark clouds appear to be gathering over the spirits…

Read More »

More analyses